Results from a test‐and‐treat study for influenza among residents of homeless shelters in King County, WA: A stepped‐wedge cluster‐randomized trial

Author:

Rogers Julia H.12ORCID,Casto Amanda M.13,Nwanne Gift3,Link Amy C.1,Martinez Miguel A.1,Nackviseth Callista1,Wolf Caitlin R.1,Hughes James P.34,Englund Janet A.5,Sugg Nancy6,Uyeki Timothy M.7,Han Peter D.8,Pfau Brian8,Shendure Jay9,Chu Helen Y.1ORCID

Affiliation:

1. Division of Allergy and Infectious Diseases, Department of Medicine University of Washington Seattle Washington USA

2. Department of Epidemiology University of Washington Seattle Washington USA

3. Vaccine and Infectious Disease Division Fred Hutchinson Cancer Research Center Seattle Washington USA

4. Department of Biostatistics University of Washington Seattle Washington USA

5. Division of Pediatric Infectious Diseases, Department of Pediatrics University of Washington, Seattle Children's Research Institute Seattle Washington USA

6. Department of Medicine University of Washington Seattle Washington USA

7. Influenza Division, National Center for Immunization and Respiratory Diseases Centers for Disease Control and Prevention Atlanta Georgia USA

8. Brotman Baty Institute for Precision Medicine Seattle Washington USA

9. Department of Genome Sciences University of Washington Seattle Washington USA

Abstract

AbstractBackgroundPersons experiencing homelessness face increased risk of influenza as overcrowding in congregate shelters can facilitate influenza virus spread. Data regarding on‐site influenza testing and antiviral treatment within homeless shelters remain limited.MethodsWe conducted a cluster‐randomized stepped‐wedge trial of point‐of‐care molecular influenza testing coupled with antiviral treatment with baloxavir or oseltamivir in residents of 14 homeless shelters in Seattle, WA, USA. Residents ≥3 months with cough or ≥2 acute respiratory illness (ARI) symptoms and onset <7 days were eligible. In control periods, mid‐nasal swabs were tested for influenza by reverse transcription polymerase chain reaction (RT‐PCR). The intervention period included on‐site rapid molecular influenza testing and antiviral treatment for influenza‐positives if symptom onset was <48 h. The primary endpoint was monthly influenza virus infections in the control versus intervention periods. Influenza whole genome sequencing was performed to assess transmission and antiviral resistance.ResultsDuring 11/15/2019–4/30/2020 and 11/2/2020–4/30/2021, 1283 ARI encounters from 668 participants were observed. Influenza virus was detected in 51 (4%) specimens using RT‐PCR (A = 14; B = 37); 21 influenza virus infections were detected from 269 (8%) intervention‐eligible encounters by rapid molecular testing and received antiviral treatment. Thirty‐seven percent of ARI‐participant encounters reported symptom onset < 48 h. The intervention had no effect on influenza virus transmission (adjusted relative risk 1.73, 95% confidence interval [CI] 0.50–6.00). Of 23 influenza genomes, 86% of A(H1N1)pdm09 and 81% of B/Victoria sequences were closely related.ConclusionOur findings suggest feasibility of influenza test‐and‐treat strategies in shelters. Additional studies would help discern an intervention effect during periods of increased influenza activity.

Funder

Centers for Disease Control and Prevention

Publisher

Wiley

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,Pulmonary and Respiratory Medicine,Epidemiology

Reference26 articles.

1. Disease burden of flu. Centers for Disease Control and Prevention.https://www.cdc.gov/flu/about/burden/index.html. Published2022. Accessed October 18 2022.

2. HenryM deSousaT RoddeyC GayenS BednarTJ.The 2020 Annual Homeless Assessment Report (AHAR) to Congrress.2020.https://www.huduser.gov/portal/sites/default/files/pdf/2020-AHAR-Part-1.pdf

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3